Portland, OR, July 19, 2022 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Computational Biology Market by Application (Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software), by Services (In-house, Contract), by End Use (Academics & Research, Commercial): Global Opportunity Analysis and Industry Forecast, 2021-2031.”According to the report, the global computational biology market generated USD 5.5 billion in 2021, and is projected to reach USD 31.5 billion by 2031, growing at a CAGR of 19.5% from 2022 to 2031. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download Report (245 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/12286
Increase in demand of pharmacovigilance, surge in the adoption and development of advanced software for drug discovery, and rise in demand for tools of computational biology in various fields such as genomics, epi-genomics, proteomics, and meta-genomics are expected to drive the growth of the global computational biology market. On the other hand, high initial cost & maintenance costs of the instruments are expected to hinder the growth to some extent. However, growing popularity of disease modeling of various diseases such as cardiovascular, cancer, and other infectious diseases is expected to create ample opportunities for the industry.
COVID-19 Scenario
- The outbreak of COVID-19 has had a positive impact on the growth of the global computational biology market, owing to the rise in fear and spread of infections among people.
- Pharmaceutical and biotech companies came together with the government to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply.
- Thus, the market is expected to experience a positive impact.
The report offers a detailed segmentation on the global computational biology market based on application, services, end use and region.
Scope of the Report: -
| Report Attribute | Details |
| The market size value in 2021 | USD 5.5 billion |
| The revenue forecast in 2031 | USD 31.5 billion |
| Growth rate | CAGR of 19.5% from 2022 to 2031 |
| Base year for estimation | 2021 |
| Historical data | 2017 - 2020 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million and CAGR from 2022 to 2030 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Application, Services, End User, Region |
| Regions covered | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | U.S.; Canada; U.K.; Germany; Italy; France; Spain; Japan; China; India; Brazil; Mexico; Argentina; South Africa; Saudi Arabia |
| Key companies profiled | Altaris Capital Partner, Compugen Ltd., Certara, Genedata AG, Dassault Systems, DNAnexus, Nimbus Discovery, Instem, Rosa & co. Ltd., and Simulation Plus. Read More |
Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/request-for-customization/12286?reqfor=covid
Based on application, the cellular and biological simulation segment held the largest market share in 2021, holding nearly one-fourth of the global market. The drug discovery and disease modelling segment, on the other hand, is predicted to cite the fastest CAGR of 20.5% during the forecast period.
Based on end use, the commercial segment held the majority market share in 2021, garnering more than two-thirds of the global market. The academics & research segment, on the other hand, is predicted to cite the fastest CAGR of 20.2% during the forecast period.
Based on region, the market across North America held the lion’s share in 2021, holding nearly two-fifths of the global market. The LAMEA region, on the other hand, is predicted to cite the fastest CAGR of 23.0% during the forecast period.
The key players analzyed in the global computational biology market report include Altaris Capital Partner, Compugen Ltd., Certara, Genedata AG, Dassault Systems, DNAnexus, Nimbus Discovery, Instem, Rosa & co. Ltd., and Simulation Plus.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the computational biology market, and the current computational biology market trends and future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis of the market from 2022 to 2031 to enable stakeholders to capitalize on the prevailing market computational biology market opportunity.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the computational biology industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
- By Application
- Cellular & Biological Simulation
- Drug Discovery & Disease Modelling
- Preclinical Drug Development
- Clinical Trials
- Human Body Simulation Software
- By Services
- Contract
- In-house
- By End Use
- Academics & Research
- Commercial
- By Region
- North America
- U.S. Computational Biology Market
- Canada Computational Biology Market
- Mexico Computational Biology Market
- Europe
- Germany Computational Biology Market
- France Computational Biology Market
- United Kingdom Computational Biology Market
- Italy Computational Biology Market
- Spain Computational Biology Market
- Rest of Europe
- Asia-Pacific
- Japan Computational Biology Market
- China Computational Biology Market
- Australia Computational Biology Market
- India Computational Biology Market
- South Korea Computational Biology Market
- Rest of Asia-Pacific
- LAMEA
- Brazil Computational Biology Market
- Saudi Arabia Computational Biology Market
- South Africa Computational Biology Market
- Rest of LAMEA
- North America
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
Trending Reports in Healthcare Industry (Book Now with 10% Discount + Covid-19 scenario):
Opioids Market size was valued at $4.4 billion in 2020 and is projected to reach $6.1 billion by 2030, growing at a CAGR of 3.2% from 2021 to 2030.
Cell Culture Market size accounted for $16,107.7 million in 2019, and is expected to reach $36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.
Spirulina Market was valued at $393.6 million in 2019, and is projected to reach $897.61 million by 2027, registering a CAGR of 10.5% from 2020 to 2027.
Antibiotics Market generated $42,335 million in 2017, and is projected to reach $50,374 million by 2025, growing at a CAGR of 2.1% from 2018 to 2025.
Menstrual Cup Market size accounted for around $632 million in 2018 and is expected to reach $963 million by 2026, registering a CAGR of 5.3% from 2019 to 2026.
Workplace Wellness Market size was valued at $49.81 billion in 2019, and is projected to reach $66.20 billion by 2027, registering a CAGR of 5.9% from 2020 to 2027.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/
